| 标题 |
LBA21 First-line (1L) datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (mTNBC) for whom immunotherapy was not an option: Primary results from the randomised, phase III TROPION-Breast02 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:R.A. Dent; Z. Shao; P. Schmid; J.C. Cortés; D.W. Cescon; et al 出版日期:2025-11-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)